Background Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative
therapy with proven efficacy in the management of hematologic malignancies. However, it is …

Allogeneic hematopoietic stem cell transplantation (HSCT) has been widely used for the
treatment of hematologic malignant and non‐malignant hematologic diseases and other …

Purpose Sezary syndrome (SS) and tumor-stage mycosis fungoides (MF) are generally
incurable with currently available treatments. We conducted a retrospective study to …

In allogeneic hematopoietic cell transplantation (HCT), donor T cell-mediated graft versus
host leukemia (GVL) and graft versus autoimmune (GVA) activity play critical roles in …

Reduced-intensity regimens (RIRs) are being used with increasing frequency in patients
with non-Hodgkin's lymphoma (NHL) undergoing allogeneic transplantation. The impact of …

We previously reported results in 71 patients with advanced hematologic malignancies
given HLA-matched unrelated granulocyte colony-stimulating factor–mobilized peripheral …

Both acute and chronic graft-versus-host disease (GVHD) are major causes of morbidity and
mortality in patients undergoing allogeneic hematopoietic stem cell transplantation …

Mycophenolate mofetil (MMF) has been widely used for the prophylaxis of graft-versus-host
disease (GvHD) in hematopoietic stem cell transplantation (HSCT), based on clinical …

Numerous lines of preclinical and clinical evidence support the existence of a graft-versus-
leukemia effect, but less evidence supporting a comparable graft-versus-lymphoma effect …

Development of nonablative and reduced-intensity conditioning regimens has enabled older
or medically infirm patients with myeloid malignancies to be treated with allogeneic …